Syngene Reports FY26 Revenue Rise And Board Changes

05 May 2026 CW Team

Net cash generated during the year was Rs. 5,210 mn after capital expenditure. Operating EBITDA for the year was Rs. 9,180 mn, down from Rs. 10,420 mn in the prior year, reflecting margin pressure. The results excluded a gratuity re-measurement credit of Rs. 200 mn and termination benefits of Rs. 250 mn recognised as exceptional. Management also disclosed an insurance settlement of Rs. 210 mn and an increase in gratuity liabilities of Rs. 380 mn.

The board confirmed several leadership changes. Kiran Mazumdar-Shaw became Executive Chairperson effective April 1, 2026 for a five-year term and Siddharth Mittal will take over as Managing Director and Chief Executive Officer effective July 1, 2026 for a five-year term. The board recommended Vijaya Chandru and Arun Chandavarkar as independent directors and reappointed Vinita Bali for one year. Maninder Kapoor Puri and Abhijit Zutshi join as Chief Human Resources Officer and Chief Commercial Officer respectively.

Syngene said it is expanding capabilities in antibody-drug conjugates and has commenced operations at an ADC discovery laboratory and a GMP bioconjugation suite to support discovery through manufacturing. The company completed 14 client and regulatory audits in the quarter and obtained GCP-NABL accreditation. An investor call was scheduled for 2 pm IST on April 30, 2026; replay is available until May 07, 2026 and a transcript will be posted within seven working days. The company serves global customers with over 8,300 employees and 3 mn sq. ft of specialised facilities.

"Join industry leaders at RAHSTA Expo, India's premier platform for roads, highways and traffic infrastructure. Register now to explore innovations, network with experts and shape the future of mobility."

Bengaluru, April 29, 2026: Syngene International Limited (Syngene) reported fourth quarter and full-year results for fiscal year 2026. Full-year revenue from operations rose three per cent to Rs. 37,390 mn and fourth quarter revenue rose two per cent year-on-year to Rs. 10,370 mn, up 13 per cent sequentially. Operating EBITDA margin for the quarter was 29 per cent and for the year 25 per cent. Profit after tax before exceptional items was Rs. 1,530 mn in the quarter and Rs. 3,800 mn for the year. Net cash generated during the year was Rs. 5,210 mn after capital expenditure. Operating EBITDA for the year was Rs. 9,180 mn, down from Rs. 10,420 mn in the prior year, reflecting margin pressure. The results excluded a gratuity re-measurement credit of Rs. 200 mn and termination benefits of Rs. 250 mn recognised as exceptional. Management also disclosed an insurance settlement of Rs. 210 mn and an increase in gratuity liabilities of Rs. 380 mn. The board confirmed several leadership changes. Kiran Mazumdar-Shaw became Executive Chairperson effective April 1, 2026 for a five-year term and Siddharth Mittal will take over as Managing Director and Chief Executive Officer effective July 1, 2026 for a five-year term. The board recommended Vijaya Chandru and Arun Chandavarkar as independent directors and reappointed Vinita Bali for one year. Maninder Kapoor Puri and Abhijit Zutshi join as Chief Human Resources Officer and Chief Commercial Officer respectively. Syngene said it is expanding capabilities in antibody-drug conjugates and has commenced operations at an ADC discovery laboratory and a GMP bioconjugation suite to support discovery through manufacturing. The company completed 14 client and regulatory audits in the quarter and obtained GCP-NABL accreditation. An investor call was scheduled for 2 pm IST on April 30, 2026; replay is available until May 07, 2026 and a transcript will be posted within seven working days. The company serves global customers with over 8,300 employees and 3 mn sq. ft of specialised facilities.

Infrastructure Urban

06 Jul 2026

ABS Marine Sees CRISIL Credit Rating Upgrade

ABS Marine Services has secured an upgrade to its long term and short term credit ratings from CRISIL, reflecting improved profitability and revenue growth through long term contracts. CRISIL moved the long term rating from BBB+/Stable to A-/Stable and revised the short term rating from A2 to A2+. The action signals strengthened financial metrics and operational resilience. The company benefited from durable client relationships with firms such as ONGC and Schlumberger. The rating decision followed stronger cash flows and an enlarged bank loan facility, which increased from Rs 3,705 million (m..

Infrastructure Transport

06 Jul 2026

Project BRAHMANK Marks 16 Years Of Strategic Roads In Arunachal

Project BRAHMANK is marking 16 years of work to establish strategic road and bridge links across Arunachal Pradesh, maintaining and developing 811 kilometres of roads and nearly 86 bridges that range from small culverts to large steel and arch bridges. These transport links are described as critical for ensuring year-round movement of defence personnel, equipment and essential supplies while improving everyday travel for people in remote villages. The project balances national security requirements with regional development by focusing on reliable access in challenging terrain. Notable enginee..

Infrastructure Transport

06 Jul 2026

Longleng CSOs Give One Week Ultimatum Over Two-Lane Highway

Civil society organisations (CSOs) in Longleng district have demanded immediate restoration of the deteriorating Changtongya–Longleng two-lane road and sought a detailed status report on the stalled construction within one week. The demand followed a consultative meeting convened under the Phom Peoples' Council (PPC) to discuss welfare and development concerns. PPC president YB Angam Phom said prolonged non-maintenance had caused hardship to commuters and affected transportation, local commerce and the district's development. The meeting urged authorities to undertake immediate restoration a..